Lone Star Oncology
2026 Fall Oncology Conference: Care, Collaboration, and Innovation (In-person only, no virtual option).
- Registration Closed
Audience: Oncologists, Oncology Nurses, Oncology APPs, Oncology Pharmacists.
Location: Embassy Suites by Hilton Houston. 11730 Katy Freeway | Houston, Texas 77079
Date: Saturday, October 03, 2026
This Conference is in-person only, no virtual options.
The PCP is providing a conference Scholarship for clinical oncology professionals. Use Code 2026FallConference to register for free (you must be in an active clinical role to use this scholarship).
Note:
1. We are unable to accommodate onsite registration. To attend, please register online (via the registration link).
2. This program is supported by a limited grant/sponsorship in support of oncology advancement, education, and oncology professional development. Therefore, we have limited spots for non-exhibiting industry partners. Industry partners should email [email protected] for any availability.
Accreditation NCPD/CE
Lone Star Oncology is approved as a provider of nursing continuing professional development by the Louisiana State Nurses Association - Approver, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 6.0 contact hours and 2.0 Pharmacotherapeutic contact hours
To receive contact hours for this nursing continuing professional development activity, the participant must:
● Sign in.
● Attend and be present for the entire presentation. No partial credit will be provided.
● Complete the evaluation after the presentation via a link provided to all participants.
● Certificates will be awarded electronically upon completion of the evaluation.
Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 6.0 NCPD contact hours and 2.0 Pharmacotherapeutic contact hours.
Accommodation/Hotel Reservation
The conference will take place at the Embassy Suites by Hilton Houston. 11730 Katy Freeway | Houston, Texas 77079
Conference attendees will receive a significantly discounted hotel rate. The reservation cut-off date is Sep. 28, 2026.
Reserve your room directly here - Lone Star Oncology 2026 Fall Oncology Conference
Lone Star Oncology reserves the right to update this information and decline participation as deemed necessary.
| Time | Topic | Speaker | Institution |
| 07:15 AM | Registration open | ||
| 07:15 – 07:45 AM | Breakfast/Registration/Net working | ||
| 08:15 – 08:30 AM | Welcome | ||
| 08:30 – 09:30 AM | Pharmacological & Clinical Update | Christina Rivera, PharmD | Houston Methodist Hospital |
| 09:30 – 10:00 AM | Diagnostic Testing and Utility of Next-Generation Sequencing | Ricardo Alvarez, M.D., MSc. | Oncology Consultants |
| 10:00 – 10:30 AM | Updates in Her2+ ABC: Standing on the Shoulders of Giants | Giancarlo Moscol, M.D. | UT MD Anderson |
| 10:30 – 10:45 AM | Break/Networking | ||
| 10:45 – 11:30 AM | Knowledge Is Power. Understanding Colorectal Cancer | Alisha Bent, M.D | UT MD Anderson |
| 11:30 – 12:00 PM | GU Cancer Update 2026 | Putao Cen, MD | UT Health Houston |
| 12:00 – 12:30 PM | Gynecologic Oncology: What Changed, What Matters, and What We Do Now | Tracilyn Hall, MD | Baylor College of Medicine |
| 12:30 – 12:45 PM | Transition Break | ||
| 12:45 – 01:30 PM | Lunch Presentation (Non-CME) | ||
| Jazz Pharmaceticals | Optimizing Patient Management With ZIIHERA in HER2-Positive Advanced Gastroesophageal Adenocarcinoma | ||
| Recordati Rare Diseases | Could Unexplained Lymphadenopathy Be a Form of Castleman Disease? | ||
| SOBI | Exploring phenotypes in myelofibrosis (MF) and the role of VONJO® (pacritinib) | ||
| 01:30 – 02:00 PM | Transisition Break | ||
| 02:00 – 02:45 PM | Lungs | Haniel Araujo, MD | UT MD Anderson |
| 02:45 – 03:15 PM | Head & Neck Cancers: Clinical Recognition, Diagnosis & Management | Omobolanle Oji, APRN | Baylor College of Medicine |
| 03:15 – 03:30 PM | Break/Networking | ||
| 03:30 – 04:00 PM | Rare Malignancies/Rare Tumors | Kristi Posey PA-C | UT MD Anderson |
| 04:00 – 04:30 PM | Survivorship in Cancer Care | Afton Dickenson | Texas Oncology |
| 04:30 PM | Evaluation | ||
| Planning Team | |||
| Giancarlo Moscol, M.D. | Conference Chair/Director | ||
| Crystal Hawkins | MD Anderson Cancer Center | ||
| Meghan Jones | MD Anderson Cancer Center | ||
| Carlyn Venable | Houston Methodist Hospital | ||
| Deatra Josiah | UTMB | ||
| Roselyn Ogunkunle | Lone Star Oncology | ||
| Maribel Bhojani | UTMB | ||
Thank you to our sponsors and supporters!
Program Sponsor - The PCP Group
Platinum Level:
Sobi Inc. Jazz Pharmaceuticals Recordati Rare Disease
Gold Level:
Chemo Mouthpiece Daiichi Sankyo
EMD Serono Hologic
Silver Level
AstraZeneca Blueprint Medicines Celcuity Merck
boehringer-ingelheim Nuvation Bio Exelixis
Novartis (Medical) Pharmacosmos Sanofi
Takeda Pharmacyclics/AbbVie Taiho Gilead
